Results 131 to 140 of about 8,656 (193)

Sleep and circadian effects on the incretin system. [PDF]

Curr Sleep Med Rep
Yuan RK, Zitting KM.
europepmc   +1 more source

Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics. [PDF]

Expert Rev Proteomics
Barrios A, Thomas SN.
europepmc   +1 more source

Recent Updates on Diabetes and Bone. [PDF]

Int J Mol Sci
Brunetti G.
europepmc   +1 more source

Impaired Brain Incretin and Gut Hormone Expression in Human Alcohol-Related Brain Damage: Opportunities for Therapeutic Targeting. [PDF]

Biomolecules
de la Monte SM, Tong M, Carlson RI, Sutherland G.   +3 more
europepmc   +1 more source

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes. [PDF]

Sci Rep
Takemoto M, Zhang BS, Hayashi A, Yamagata H, Yoshida Y, Koshizaka M, Onishi S, Yamaga M, Yoshida T, Hashimoto T, Ohtake N, Ishikawa T, Takizawa H, Hiwasa T.   +13 more
europepmc   +1 more source

Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.

J Clin Endocrinol Metab
Di Giuseppe G, Gliozzo G, Ciccarelli G, Carciero L, Brunetti M, Soldovieri L, Quero G, Cinti F, Nista EC, De Lucia SS, Gasbarrini A, Alfieri S, Pontecorvi A, Mari A, Hartmann B, Holst JJ, Giaccari A, Mezza T.   +17 more
europepmc   +1 more source

Incretins: mechanistic insights, clinical realities, and translational perspectives in type 2 diabetes and obesity. [PDF]

Diabetol Int
Yabe D.
europepmc   +1 more source

Is there still room for pioglitazone in contemporary type 2 diabetes management? [PDF]

Cardiovasc Diabetol
Caruso I.
europepmc   +1 more source